Pharmaceutical

STAT+: ‘We’re getting much more aggressive’: Microsoft’...

“The field is open for Nuance to really accelerate their product development and...

STAT+: Karuna’s treatment for schizophrenia achieves st...

Karuna Therapeutics said its treatment for schizophrenia reduced psychosis repor...

Watch: P-value, an important measurement in clinical tr...

In this short video, @damiangarde explains what p-value is, how it is used, and ...

Opinion: Will there be any emergency doctors to see you...

The decline in students’ interest in emergency medicine does not only affect the...

STAT+: Hospitals are not crumbling, Medicare experts te...

Hospitals’ financial situations are not nearly as dire as industry groups are ma...

‘That scares me’: New childhood obesity guidelines stil...

Experts told STAT that the new pediatric obesity guidelines were out of touch wi...

‘A safe place to fail’: ARPA-H chief on building a cult...

Renee Wegrzyn, director of ARPA-H and part of the 2023 #STATUSList, explains her...

US FDA approves Novartis’ Tafinlar and Mekinist combina...

The approval of the combination of Tafinlar and Mekinist is based on the Phase I...

UCB enters drug discovery collaboration with Aitia

The collaboration will combine the use of new drug targets for the disease from ...

Talem and Libera Bio partner for discovery of AI-driven...

The collaboration will use the LENSai Full Suite of Integrated Intelligence Tech...

Which biotechs need to find a new bank after the collap...

One immediate outcome of Silicon Valley Bank’s collapse will be its former clien...

Legal challenges put off label use of gender affirming ...

Experts debunk gender-affirming care safety concerns and detail logistical barri...

UK MHRA grants marketing authorisation for argenx’s gMG...

Vyvgart’s approval is based on the data obtained from the global Phase III ADAPT...

Tapping into digital therapeutics to improve neurologic...

Despite advancing research, clinical data and timely reimbursement are crucial f...

Risk sharing agreements soar as market access risk incr...

GlobalData analysts detail a rise in risk sharing agreements with pharma compani...

LCRF, Daiichi Sankyo and AstraZeneca enter research col...

The partnership is intended to request proposals for research grants focused on ...